探索最近的小分子在抗疟疾药物武器库中的开创性发展:化学前景评估
Tameika Bagratee1, Ritika Prawlall1, Thabani Ndlovu1
1Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal (Westville), Durban, 4000, South Africa.
Chemistry & biodiversity
|May 17, 2024
概括
耐药疟疾需要新的治疗方法. 混合抗疟疾化合物,结合多种药物特性,显示出下一代针对虫寄生虫的治疗方法的希望.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 疟疾仍然是一个重大的全球健康威胁,每年造成数百万人的死亡.
- 对当前的抗疟疾药物产生新兴的寄生虫抗性需要新的治疗策略.
- 由于广泛的耐药性,现有的治疗方法越来越无效.
研究的目的:
- 审查通过药物化学开发的混合抗疟疾药物的最新进展.
- 探索具有强大的抗疟疾特性和降低毒性的新型小分子.
- 为设计下一代针对各种寄生虫生命阶段的抗疟疾药物提供基础.
主要方法:
- 从2021年到现在的混合抗疟剂的综合文献综述.
- 专注于合成和评估抗疟疾活性的小分子.
- 对针对寄生虫双重和多阶段生命周期的化合物的分析.
主要成果:
- 药物化学的努力已经产生了具有显著抗疟疾潜力的新型小化合物.
- 与传统药物相比,混合分子显示出强大的疗效和降低的毒性.
- 几种化合物显示出有望针对虫寄生虫生命周期的不同阶段.
结论:
- 混合抗疟药剂是克服耐药性的有希望的策略.
- 药物化学的持续研究对于开发有效的下一代疟疾治疗方法至关重要.
- 这些新型化合物为全球抗击疟疾提供了新的视角.
相关概念视频
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K


